Heterogeneity within Corynebacterium minutissimum strains is explained by misidentified Corynebacterium amycolatum strains.

Forty-eight clinical strains that were tentatively identified as Corynebacterium minutissimum on the basis of standard biochemical reactions (Hollis-Weaver tables) as well as by the use of the API (RAPID) Coryne system were examined further. Two different groups of strains were observed. The first group (including the type strain of C minutissimum) contained 27 strains showing creamy colonies. These strains grew homogeneously in 6.5% NaCl broth, exhibited DNase activity, were susceptible to the vibriocidal compound O/129, produced succinic acid, and contained mycolic acids. The second group comprised 21 strains with dry colonies. They grew in clumps at the surface of 6.5% NaCl broth, DNase activity was not detected, they were resistant against O/129, produced large amounts of propionic acid, and mycolic acids were not detected. In combination with quantitative DNA-DNA hybridizations, it was demonstrated that strains of the second cluster belonged, in fact, to C amycolatum. Furthermore, it was observed that a few C minutissimum strains may also ferment mannitol. These data indicate that the clinical microbiologist must be careful not to misidentify C amycolatum strains as C minutissimum.

[1]  G. Funke,et al.  Antimicrobial susceptibility patterns of some recently established coryneform bacteria , 1996, Antimicrobial agents and chemotherapy.

[2]  M. Collins,et al.  Identification of some clinical strains of CDC coryneform group A-3 and A-4 bacteria as Cellulomonas species and proposal of Cellulomonas hominis sp. nov. for some group A-3 strains , 1995, Journal of clinical microbiology.

[3]  F. Soriano,et al.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents , 1995, Antimicrobial agents and chemotherapy.

[4]  M. Marchiani,et al.  Characteristics of CDC group 1 and group 1-like coryneform bacteria isolated from clinical specimens , 1993, Journal of clinical microbiology.

[5]  C. Bizet,et al.  Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin , 1993, Journal of clinical microbiology.

[6]  R. Leonard,et al.  Evaluation of the rapid CORYNE identification system for Corynebacterium species and other coryneforms , 1992, Journal of clinical microbiology.

[7]  G. Osterhout,et al.  Grouping of some clinically relevant Gram‐positive rods by automated fatty acid analysis , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[8]  J. Freney,et al.  Evaluation of API Coryne in comparison with conventional methods for identifying coryneform bacteria , 1991, Journal of clinical microbiology.

[9]  Benjamin A Lipsky,et al.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects , 1990, Clinical Microbiology Reviews.

[10]  M. Collins,et al.  Corynebacterium amycolatum sp. nov. a new mycolic acid-less Corynebacterium species from human skin , 1988 .

[11]  B. Thiers,et al.  [Micromethods and gas chromatography analysis of carboxylic acids produced from the fermentation of glucose in the identification of Corynebacteria]. , 1987, Annales de biologie clinique.

[12]  S. Falkow,et al.  Use of a Single-Strand Specific Nuclease for Analysis of Bacterial and Plasmid Deoxyribonucleic Acid Homo- and Heteroduplexes , 1973, Journal of bacteriology.